CHICAGO, IL (June 2, 2020) – BioForce Nanosciences, Inc. has entered into a joint venture agreement with German-based High Tech company n.able GmbH. This arrangement enables customers in the United States and Europe access to molecular printing and micro deposition instruments from both companies. Products offered will span the combined complementary technologies portfolios of both groups. Additional information is available through the individual companies’ websites or direct emails to the sales teams.
Since 2005, BioForce Nanosciences, Inc. has developed and commercialized nanotech instruments including the Nano eNabler Molecular Printer, UV/Ozone ProCleaner, consumables and applications for the life sciences industry. BioForce Nanosciences, Inc. is independently operated and has no affiliation with BioForce Nanosciences Holdings (BFNH). Additional information about BioForce Nanosciences can be found at www.bioforcenano.com.
Founded in 2019 as a spin-off at the Institute of Nanotechnology, Karlsruhe Institute of Technology, n.able is a young team of scientists and business professionals with more than 10 years of experience in the field of surface functionalization in the micro- and nano-scale. n.able has developed a Molecular Deposition Desktop Printer, consumables and services for the fields of biology, medicine, photonics and material research. Additional information about n.able can be found at www.n-able-innovation.com.
# # #
Comments are closed.